14 September 2020>: Clinical Research
Do We Need to Distinguish Thrombolysis and Nonthrombolysis Patients When Applying Stroke-Associated Pneumonia Predicting Scores? An External Validation from a 2-Center Database
Jiao Jiao 123ABCDEF , Leiyu Geng 123BG , Zhijun Zhang 123ADF*DOI: 10.12659/MSM.924129
Med Sci Monit 2020; 26:e924129
Table 1 Baseline characteristics of the entire group, non-thrombolysis subgroup and thrombolysis subgroup.
Entire group (n=276) | Non-thrombolysis subgroup (n=138) | Thrombolysis subgroup (n=138) | Statistic | P value | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Age | ||||||||||
7, 5.07% | ||||||||||
50–60 | 21, 15.22% | |||||||||
61–70 | 41, 29.71% | |||||||||
71–80 | 40, 28.99% | |||||||||
81–90 | 27, 19.57% | |||||||||
>90 | 3, 2.17% | |||||||||
Gender | 0.063 | 0.802 | ||||||||
Male | 176 | 89 | 87 | |||||||
Female | 100 | 49 | 51 | |||||||
Present smoking | 0.319 | 0.572 | ||||||||
Yes | 66 | 31 | 35 | |||||||
No | 210 | 107 | 103 | |||||||
COPD | 0.070 | |||||||||
Yes | 15 | 7 | 8 | 0.791 | ||||||
No | 261 | 131 | 130 | |||||||
Congestive heart Failure | 0.115 | 1.000 | ||||||||
Yes | 9 | 5 | 4 | |||||||
No | 267 | 133 | 134 | |||||||
Atrial fibrillation | 2.183 | 0.14 | ||||||||
Yes | 58 | 24 | 34 | |||||||
No | 218 | 114 | 104 | |||||||
Dysphagia | 32.504 | ** | ||||||||
Yes | 95 | 25 | 70 | |||||||
No | 181 | 113 | 68 | |||||||
mRS | 0.39±0.89 | 0.44±0.92 | 0.33±0.87 | −1.053 | 0.293 | |||||
Systolic pressure | 153.38±23.04 | 152.29±20.67 | 154.47±25.21 | 0.77 | 0.562 | |||||
Glucose (mmol/L) | 7.88±4.06 | 7.48±3.57 | 8.28±4.47 | 1.65 | 0.101 | |||||
WBC (×10/L) | 7.79±2.59 | 7.44±2.29 | 8.14±2.8 | 2.29 | 0.039* | |||||
GCS | 13.28±2.26 | 14.09±1.76 | 12.46±2.41 | −6.413 | ** | |||||
NIHSS | 6.38±6.33 | 3.80±4.98 | 8.96±6.50 | 7.405 | ** | |||||
OCSP | 6860.5 | ** | ||||||||
Lacunar infarction | 12 | 3 | 9 | |||||||
TACI | 32 | 1 | 31 | |||||||
PACI | 185 | 106 | 79 | |||||||
POCI | 46 | 28 | 18 | |||||||
* p ** p |